Cas 1429026-08-3,3-(trifluoromethyl)-6-(5-fluoro-3'-methoxybiphenyl-2-yloxy)-[1,2,4]triazolo[4,3-b]pyridazine

1429026-08-3

Post Buying Request

Basic information

Product Name: 3-(trifluoromethyl)-6-(5-fluoro-3'-methoxybiphenyl-2-yloxy)-[1,2,4]triazolo[4,3-b]pyridazine
Synonyms: 3-(trifluoromethyl)-6-(5-fluoro-3'-methoxybiphenyl-2-yloxy)-[1,2,4]triazolo[4,3-b]pyridazine
CAS NO:1429026-08-3
Molecular Formula:
Molecular Weight: 404.323
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 3-(trifluoromethyl)-6-(5-fluoro-3'-methoxybiphenyl-2-yloxy)-[1,2,4]triazolo[4,3-b]pyridazine(CAS DataBase Reference)
NIST Chemistry Reference: 3-(trifluoromethyl)-6-(5-fluoro-3'-methoxybiphenyl-2-yloxy)-[1,2,4]triazolo[4,3-b]pyridazine(1429026-08-3)
EPA Substance Registry System: 3-(trifluoromethyl)-6-(5-fluoro-3'-methoxybiphenyl-2-yloxy)-[1,2,4]triazolo[4,3-b]pyridazine(1429026-08-3)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1429026-08-3(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1429026-08-3 Suppliers

Recommended suppliers

1429026-08-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1429026-08-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,2,9,0,2 and 6 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1429026-08:
(9*1)+(8*4)+(7*2)+(6*9)+(5*0)+(4*2)+(3*6)+(2*0)+(1*8)=143
143 % 10 = 3
So 1429026-08-3 is a valid CAS Registry Number.

1429026-08-3Upstream product

1429026-08-3Downstream Products

1429026-08-3Relevant academic research and scientific papers

DERIVATIVES OF 6-SUBSTITUTED TRIAZOLOPYRIDAZINES AS REV-ERB AGONISTS

-

Page/Page column 43-44; 102, (2013/04/13)

The present invention provides novel 6-substituted [1,2,4]triazolo[4,3-b]pyridazines that are agonists of Rev-Erb. These compounds, and pharmaceutical compositions comprising the same, are suitable means for treating any disease wherein the activation of Rev-Erb has therapeutic effects, for instance in inflammatory and circadian rhythm-related disorders or cardiometabolic diseases.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1429026-08-3